SGT-277

出自Local Chinese Wikipedia
跳至導覽 跳至搜尋
SGT-277
File:CUMYL-CBMINACA structure.png
法律規範狀態
法律規範
識別資訊
  • 1-(cyclobutylmethyl)-N-(2-phenylpropan-2-yl)indazole-3-carboxamide
CAS號3001262-62-7
PubChem CID
ChemSpider
UNII
化學資訊
化學式C22H25N3O
摩爾質量347.46 g·mol−1
3D模型(JSmol
  • CC(C)(NC(=O)c3nn(CC1CCC1)c2ccccc23)c4ccccc4
  • InChI=1S/C22H25N3O/c1-22(2,17-11-4-3-5-12-17)23-21(26)20-18-13-6-7-14-19(18)25(24-20)15-16-9-8-10-16/h3-7,11-14,16H,8-10,15H2,1-2H3,(H,23,26)
  • Key:CFMZQSDQCNKGII-UHFFFAOYSA-N

SGT-277,或稱為CUMYL-CBMINACA,分子式C
22
H
25
N
3
O
,屬於吲唑-3-甲醯胺類SGT系列大麻素[1],2020年2月首次在德國被發現[2]

參考文獻[編輯]

  1. Haschimi B, Grafinger KE, Pulver B, Psychou E, Halter S, Huppertz LM, et al. New synthetic cannabinoids carrying a cyclobutyl methyl side chain: Human Phase I metabolism and data on human cannabinoid receptor 1 binding and activation of Cumyl-CBMICA and Cumyl-CBMINACA. Drug Testing and Analysis. August 2021, 13 (8): 1499–1515. PMID 33788409. doi:10.1002/dta.3038可免費查閱. 
  2. EU Early Warning System Situation Report. Situation report 1 (PDF). European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). June 2020.